Juan R. Luciano’s recent SEC Form 4 activity across Eli Lilly (LLY) and Archer-Daniels-Midland (ADM) reveals a pattern dominated by compensation mechanics rather than discretionary market timing. Over the trailing period, the filings show zero open-market purchases (Code P) and zero open-market sales (Code S), with the entire $821,367 in total acquired value stemming from automatic grant awards (Code A) and option exercises (Code M). The most significant transaction occurred on February 5, 2026, when Luciano exercised options valued at $19.28 million in ADM, though this was immediately offset by a corresponding $27.93 million tax-withholding event (Code F) — a mechanical disposition that returned shares to the company rather than a cash-generating sale.
The recurring monthly LLY grants, each valued at roughly $14,800 to $15,900, reflect scheduled equity compensation vesting rather than conviction buying, with the November 17, 2025 award of $219,999 standing as the largest single grant. Similarly, the ADM activity in early February 2026 shows a cluster of Code F tax-withholding events totaling over $4.8 million alongside two zero-value Code A grants, indicating a vesting period rather than a strategic position change. Notably, the February 9, 2026 filings include two separate tax-withholding dispositions worth $2.40 million and $851,810, suggesting a concentrated equity release.
The absence of any Code P or S transactions across all 46 filings is the defining characteristic here — Luciano has not initiated a single discretionary buy or sell during this window. Instead, every transaction falls into the automatic categories of grants, option exercises, or tax withholdings, which are scheduled events tied to compensation plans rather than expressions of market outlook. The pattern points to a passive accumulation of LLY shares through recurring monthly awards while ADM activity centers on the mechanical processing of vested options, with no evidence of directional betting in either equity.
AI-assisted summary